110 related articles for article (PubMed ID: 7378100)
1. [Urinary copper excretion from rats following administration of aliphatic and alicyclic polyamines (author's transl)].
Harders H; Armah B; Cohnen E; Führ J; Heinz N; Schröder HF
Arzneimittelforschung; 1980; 30(2):254-8. PubMed ID: 7378100
[TBL] [Abstract][Full Text] [Related]
2. Copper chelating agents. A comparison of cupruretic responses to various tetramines and D-penicillamine.
Borthwick TR; Benson GD; Schugar HJ
J Lab Clin Med; 1980 Apr; 95(4):575-80. PubMed ID: 7359013
[TBL] [Abstract][Full Text] [Related]
3. Tetramine cupruretic agents: a comparison in dogs.
Allen KG; Twedt DC; Hunsaker HA
Am J Vet Res; 1987 Jan; 48(1):28-30. PubMed ID: 3826839
[TBL] [Abstract][Full Text] [Related]
4. The cupruretic effect of two chelators following copper loading in sheep.
Botha CJ; Naude TW; Swan GE; Dauth J; Dreyer MJ; Williams MC
Vet Hum Toxicol; 1993 Oct; 35(5):409-13. PubMed ID: 8249262
[TBL] [Abstract][Full Text] [Related]
5. Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients.
Lu J; Chan YK; Gamble GD; Poppitt SD; Othman AA; Cooper GJ
Drug Metab Dispos; 2007 Feb; 35(2):221-7. PubMed ID: 17108057
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic modeling of a copper-selective chelator (TETA) in healthy adults.
Cho HY; Blum RA; Sunderland T; Cooper GJ; Jusko WJ
J Clin Pharmacol; 2009 Aug; 49(8):916-28. PubMed ID: 19602718
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Cuprimine and Syprine for decorporation of (60)Co and (210)Po.
Levitskaia TG; Creim JA; Curry TL; Luders T; Morris JE; Woodstock AD; Levinson B; Thrall KD
Health Phys; 2010 Mar; 98(3):471-9. PubMed ID: 20147789
[TBL] [Abstract][Full Text] [Related]
8. Concurrent administration of D-penicillamine and zinc has no advantages over the use of either single agent on copper excretion in the rat.
Domingo JL; Gómez M; Jones MM
Toxicology; 1998 Apr; 126(3):195-201. PubMed ID: 9674967
[TBL] [Abstract][Full Text] [Related]
9. [Studies on determining the mutagenicity risk of triethylenetetramine (author's transl)].
Heinz N; Schröder HF
Arzneimittelforschung; 1981; 31(6):950-3. PubMed ID: 7020706
[TBL] [Abstract][Full Text] [Related]
10. The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance.
Gibbs K; Walshe JM
Clin Sci Mol Med; 1977 Oct; 53(4):317-20. PubMed ID: 913055
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of D-penicillamine in man.
Wiesner RH; Dickson ER; Carlson GL; McPhaul LW; Go VL
J Rheumatol Suppl; 1981; 7():51-5. PubMed ID: 6939886
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, pharmacodynamics, and metabolism of triethylenetetramine in healthy human participants: an open-label trial.
Lu J; Poppitt SD; Othman AA; Sunderland T; Ruggiero K; Willett MS; Diamond LE; Garcia WD; Roesch BG; Cooper GJ
J Clin Pharmacol; 2010 Jun; 50(6):647-58. PubMed ID: 20145262
[TBL] [Abstract][Full Text] [Related]
13. [Spontaneous and DL-penicillamine-induced renal copper excretion in liver diseases (author's transl)].
Friedrich K; Henning H
Z Gastroenterol; 1979 Mar; 17(3):171-6. PubMed ID: 433370
[TBL] [Abstract][Full Text] [Related]
14. Chelation in metal intoxication X: Influence of different polyaminocarboxylic acids and thiol chelators in the excretion and tissue distribution of 54Mn in rat.
Tandon SK; Khandelwal S
Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):337-40. PubMed ID: 7100634
[TBL] [Abstract][Full Text] [Related]
15. 2,3,2-tetramine--a potent cupruretic agent.
Borthwick TR; Benson GD; Schugar HJ
Proc Soc Exp Biol Med; 1979 Oct; 162(1):227-8. PubMed ID: 504234
[No Abstract] [Full Text] [Related]
16. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
17. Effects of some chelating agents on urinary copper excretion by the rat.
Jones MM; Singh PK; Zimmerman LJ; Gomez M; Albina ML; Domingo JL
Chem Res Toxicol; 1995; 8(7):942-8. PubMed ID: 8555409
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of d-penicillamine and trientine as copper chelators using an in vitro technique involving ovine red blood cells.
Botha CJ; Naude TW; Swan GE; Guthrie AJ
Onderstepoort J Vet Res; 1992 Sep; 59(3):191-5. PubMed ID: 1437021
[TBL] [Abstract][Full Text] [Related]
19. Effect of chelators on copper metabolism and copper pools in mouse hepatocytes.
McArdle HJ; Gross SM; Creaser I; Sargeson AM; Danks DM
Am J Physiol; 1989 Apr; 256(4 Pt 1):G667-72. PubMed ID: 2705527
[TBL] [Abstract][Full Text] [Related]
20. Trace metal interactions in vivo: inorganic cobalt enhances urinary copper excretion without producing an associated zincuresis in rats.
Rosenberg DW; Kappas A
J Nutr; 1989 Sep; 119(9):1259-68. PubMed ID: 2795240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
